bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.25.661429

Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair

Abstract

Vocal fold (VF) scarring is a leading cause of poor voice, yet no therapies exist to prevent its progression. Current treatments, such as intracordal steroid injections, offer limited efficacy and carry significant off-target toxicities. To identify targeted anti-scarring strategies, we performed transcriptomics of human VF myofibroblasts, the cellular drivers of VF scarring, and identified the proteoglycan decorin (DCN) as downregulated in activated myofibroblasts. We also show a time-dependent decrease in DCN during fibrotic wound healing in a preclinical rat model of VF scarring. Administration of DCN suppressed VF myofibroblast activation by reducing pro-fibrotic gene expression, -smooth muscle actin (-SMA) levels, and cell contractility. DCN was encapsulated in hyaluronic acid microgels for sustained protein release for 3-4 weeks. In a rat model of VF scarring, DCN-loaded microgels prevented hallmark features of scarring, including collagen deposition and myofibroblast activation. These findings highlight DCN as a promising therapeutic and provide a sustained delivery platform with translational potential against VF scarring. TeaserControlled decorin drug delivery from hyaluronic acid microgels attenuates myofibroblast activation to prevent vocal fold scarring, offering a translational strategy to improve post-injury voice outcomes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Friedman, R., Brown, E. A., Bonelli, H. M., Gupta, Y., Aronson, M., McDaid, K., Oh, H. M.-Y., Bandora, E. A., Zur, K. B., Gottardi, R.. 2025-06-28. Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair. https://doi.org/10.1101/2025.06.25.661429

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Dynamic Compression Platform for Live Imaging of Scaffold-Transmitted Cellular Mechanoresponses

Mechanical characterization of biomaterial scaffolds is essential to evaluate their capacity to meet the functional demands of target tissues in tissue engineering and regenerative medicine applications. Scaffolds designed to interface with living tissues must support the transmission of mechanical cues to resident cells and stimulate mechanosignaling pathways that are essential to their function. In joints, bone and cartilage cells act as primary mechanosensors, converting mechanical stimuli into biochemical signals that regulate tissue homeostasis and remodelling. Therefore, evaluating cellular mechanoresponses to scaffold-transmitted compression in vitro can inform the development of functional tissue-engineered constructs. For example, poly({epsilon}-caprolactone) (PCL) scaffolds are highly relevant for bone and cartilage tissue engineering due to their biocompatibility, stable mechanical properties and slow degradation. Here, we applied a custom-built device to study compression-induced mechanosignaling in MC3T3-E1 pre-osteoblast cells. The device is composed of a polydimethylsiloxane (PDMS) pillar, a force-sensing load cell, and a piezoelectric linear track. A protocol is described in which MC3T3-E1 cells are repeatedly compressed, while in parallel live tracking of force measurements and live imaging of intracellular calcium dynamics in MC3T3-E1 cells are recorded. PCL scaffolds fabricated by melt electrowriting (MEW) were subsequently integrated into the platform. Scaffold-transmitted compression triggered dynamic increases in cytosolic calcium; in MC3T3-E1 cells located directly under the PCL microfibers, but also in cells located in the interfiber spaces. This device and workflow facilitate in vitro investigations of real-time cellular mechanoresponses to dynamic compression applied with biomaterial scaffolds, and provides a testing platform for evaluating the mechanotransductive properties of scaffolds intended for tissue engineering applications.

bioengineering↗

Ultrasound Tracking Reveals Progressive Regional Strain Differences in Human Achilles Tendons During Fatigue Loading

Ultrasound is commonly used to assess structural changes in symptomatic Achilles tendons, but quantitative biomechanical metrics for progressive tendon deterioration remain limited. The goal of this study was to develop and validate an automated ultrasound tracking algorithm for regional tendon deformation and evaluate strain progression in survived and ruptured tendons during fatigue loading. We hypothesized that maximum strain, average strain, and strain heterogeneity would exhibit different trajectories between groups. Ten cadaveric Achilles tendons underwent cyclic loading with stress tests every 500 cycles until rupture or 150,000 cycles. Ultrasound images acquired during stress tests were analyzed using an automated tracking algorithm to generate spatially resolved regional strain fields. Ultrasound-derived bulk strain was highly correlated with actuator-derived strain in survived (R^2 = 0.968 +/- 0.017) and ruptured tendons (R^2 = 0.972 +/- 0.014). Maximum and average longitudinal strains progressively diverged between groups across fatigue life (Group x FatigueLife: p = 0.003 and p < 0.0001, respectively). During the first 10,000 cycles, average strain decreased in survived tendons ({beta} = -0.0268%, p = 0.0215) but not ruptured tendons ({beta} = 0.0147%, p = 0.1197), with a significant Group x Cycle interaction (p = 0.0061). This study demonstrates that the algorithm quantified Achilles tendon deformation with high fidelity and enabled spatially resolved strain assessment throughout fatigue loading. Maximum and average strain followed different trajectories between groups, whereas strain heterogeneity did not. Early differences in tendon biomechanics suggest that regional strain behavior may change before pronounced differences in absolute magnitude develop.

bioengineering↗

Brain organoid computing for robotic decision-making

Biomimicry has inspired the evolution of robotics toward greater autonomy, adaptability, and symbiosis with humans and dynamic environments. However, current robotic systems still face major challenges in recapitulating the high-efficiency decision-making capabilities of the human brain under complex and dynamic conditions. Here, we present Brainobot, a biohybrid robotic system that establishes a brain organoid controller as a high-level robotic decision-making layer for closed-loop embodiment. By leveraging brain organoid reservoir computing, Brainobot interacts with dynamic environments by receiving and processing sensory inputs and generating motor actions. As a proof-of-concept demonstration, Brainobot is implemented in a humanoid robotic system to perform real-world tasks, including object grasping and laser chasing. Interestingly, Brainobot exhibits unique features, including cross-task adaptivity, high computing efficiency, and low energy consumption. Thus, our approach may provide insights for advancing robotic embodiment and understanding biological decision-making.

bioengineering↗